Literature DB >> 20403926

More than measurement: practice team experiences of screening for type 2 diabetes.

Jonathan Graffy1, Julie Grant, Kate Williams, Simon Cohn, Sara Macbay, Simon Griffin, Ann Louise Kinmonth.   

Abstract

BACKGROUND: The feasibility, cost-effectiveness and best means to implement population screening for type 2 diabetes remain to be established.
OBJECTIVE: To learn from the experiences of practice staff undertaking a diabetes screening programme in order to inform future screening initiatives.
METHODS: Qualitative analysis of interviews with staff in six general practices in the 'ADDITION-Cambridge' trial; three randomly allocated to intensively manage screen-detected patients and three providing usual care. We conducted semi-structured interviews with seven nurses, four doctors, three health care assistants and four managers. Four researchers analysed the transcripts practice by practice, preparing vignettes and comparing interpretations. Participants commented on a summary report.
RESULTS: Each practice team implemented the screening and intervention programme differently, depending on numbers at risk and decisions about staff contributions. Several emphasized the importance of administrative support. As they screened, they extended the reach of the programme, testing patients outside the target group if requested, checking other risk factors, providing health information and following up people with impaired glucose tolerance. Staff felt that patients accepted the screening and subsequent management as any other clinical activity.
CONCLUSIONS: Although those developing screening programmes attempt to standardize them, primary care teams need to adapt the work to fit local circumstances. Staff need a sense of ownership, training, well-designed information technology systems and protected time. Furthermore, screening is more than measurement; at the individual level, it is a complete health care interaction, requiring individual explanations, advice on health-related behaviour and appropriate follow-up. The UK 'NHS Health Checks' programme should embrace these findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403926      PMCID: PMC2908159          DOI: 10.1093/fampra/cmq022

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  17 in total

1.  Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions.

Authors:  Graeme Wylie; A Pali S Hungin; Joanne Neely
Journal:  BMJ       Date:  2002-05-18

2.  Complex interventions: how "out of control" can a randomised controlled trial be?

Authors:  Penelope Hawe; Alan Shiell; Therese Riley
Journal:  BMJ       Date:  2004-06-26

3.  The costs of non-insulin-dependent diabetes mellitus.

Authors:  K G Alberti
Journal:  Diabet Med       Date:  1997-01       Impact factor: 4.359

4.  Screening for Type 2 diabetes: is it worthwhile? Views of general practitioners and practice nurses.

Authors:  D L Whitford; S S Lamont; A Crosland
Journal:  Diabet Med       Date:  2003-02       Impact factor: 4.359

5.  Diabetes risk score: towards earlier detection of type 2 diabetes in general practice.

Authors:  S J Griffin; P S Little; C N Hales; A L Kinmonth; N J Wareham
Journal:  Diabetes Metab Res Rev       Date:  2000 May-Jun       Impact factor: 4.876

6.  Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.

Authors:  U Rajala; M Laakso; Q Qiao; S Keinänen-Kiukaanniemi
Journal:  Diabetes Care       Date:  1998-10       Impact factor: 19.112

7.  A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care.

Authors:  C J Greaves; J W Stead; A T Hattersley; P Ewings; P Brown; P H Evans
Journal:  Fam Pract       Date:  2004-02       Impact factor: 2.267

8.  Opportunistic screening for diabetes in routine clinical practice.

Authors:  Mark W Ealovega; Bahman P Tabaei; Michael Brandle; Ray Burke; William H Herman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

9.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

Review 10.  Process evaluation in randomised controlled trials of complex interventions.

Authors:  Ann Oakley; Vicki Strange; Chris Bonell; Elizabeth Allen; Judith Stephenson
Journal:  BMJ       Date:  2006-02-18
View more
  2 in total

1.  Scalable office-based health care.

Authors:  Gabriel A Koepp; Chinmay U Manohar; Shelly K McCrady-Spitzer; James A Levine
Journal:  Health Serv Manage Res       Date:  2011-05

2.  How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial.

Authors:  Michael Laxy; Edward C F Wilson; Clare E Boothby; Simon J Griffin
Journal:  BMJ Open       Date:  2018-06-14       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.